p16INK4a expression as a potential marker of low-grade cervical intraepithelial neoplasia progression

APMIS

Volumn 123, Issue 3, 2015, Pages 185-189

  da Costa, Larissa Bastos Eloy ^a   Triglia, Renata De Marchi ^a   França Junior, Marcondes Cavalcante ^a   Andrade, Liliana A Lucci De Angelo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cervical intraepithelial neoplasia; CIN progression; HPV; P16INK4a

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; COHORT ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; TUMOR DIAGNOSIS; TUMOR GROWTH; TUMOR REGRESSION; UTERINE CERVIX CARCINOMA IN SITU; ADOLESCENT; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84923431690     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12338     Document Type: Article

References (30)

1. INK4A immunoexpression and HPV in Situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial Neoplasia. Am J Surg Pathol 2005;29:674-9.
2. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
4. Jeon S, Allen-Hoffmann BL, Lambert PF. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995;69:2989-97.
5. Östor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186-92.
6. Meijer CJ, Walboomers JM. Cervical cytology after 2000: where to go? J Clin Pathol 2000;53:41-3.
7. Snidjers PJ, van den Brule AJ, Meijer CJ. The clinical relevance of HPV testing: relationship between analytical and clinical sensitivity. J Pathol 2003;201:1-6.
8. Helmerhorst TJ, Meijer CJ. Cervical cancer should be considered as a rare complication of oncogenic HPV infection rather than a STD. Int J Gynecol Cancer 2002;12:235-6.
9. INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-84.
10. ink4a and HPV L1 Immunohistochemistry is helpful for estimating the behavior of Low-grade dysplastic lesions of the cervix uteri. Am J Surg Pathol 2008;32:1715-20.
11. INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch 2004;445:616-20.
12. Chang MS, Oh S, Jung EJ, Park JH, Jeon HW, Lee TS, et al. High-risk human papillomavirus load and biomarkers in cervical intraepithelial neoplasia and cancer. APMIS 2014;122:427-36.
13. INK4a as a marker of clinical evolution in patients with cervical intraepithelial neoplasia grade 3 (CIN 3) treated by cervical conization. APMIS 2014;122:192-9.
14. Benevolo M, Mottolese M, Marandino F, Vocaturo G, Sindico R, Piperno G, et al. Immunohistochemical expression of p16 is predicitive of HR-HPV infection in cervical low-grade lesions. Mod Pathol 2006;19:384-91.
15. INK4a immunochemistry in cervical histopathology and cytology: an update of recent developments. Int J Cancer 2014; doi: 10.1002/ijc.28900. [Epub ahead of print].
16. INK4a-imposed G1 cell cycle arrest. J Virol 2001;75:4705-12.
17. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papilloma virus oncogenic potential in cervical and genital lesions. Am J Pathol 1998;153:1741-8.
18. von Knebel Doeberitz M. New markers for cervical dysplasia to visualize the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002;38:2229-42.
19. Solomon D, Nayar R, editors. The Bethesda System for Reporting Cervical Cytology, 2nd edn. New York: Springer, 2004.
20. World Health Organization (WHO). Comprehensive Cervical Cancer Control: A Guide to Essential Practice. Geneva: WHO Library Catalloguing, 2006.
21. Tavassoli FA, Devilee P (eds). Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: World Health Organization Classification of Tumors, IARC, 2003.
22. Herfs M, Crum CP. Laboratory management of cervical intraepithelial Neoplasia: proposing a new paradigm. Adv Anat Pathol 2013;20:86-94.
23. Litjens RJNTM, Van de Vijver KK, Hopman AHN, Ummelena MI, Speel EJM, Sastrowijoto SH, et al. The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3. Hum Pathol 2014;45:221-6.
24. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907.
25. Mulvany NJ, Allen DG, Wilson SM. Diagnostic utility of p16: a reappraisal of its use in cervical biopsies. Pathology 2008;40:335-44.
26. Gatta LB, Berenzi A, Balzarini P, Dessy E, Angiero F, Alessandri G, et al. Diagnostic implications of L1, p16 and Ki67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia. Int J Gynecol Pathol 2011;30:597-604.
27. Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated lesions: background and consensus recommendations from the college of American pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med 2012;136:1266-97.
28. INK4A to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix. Int J Gynecol Pathol 2007;26:223-8.
29. Ozaki S, Zen Y, Inoue M. Biomarker expression in cervical intraepithelial neoplasia: potential progression predictive factors for low-grade lesions. Hum Pathol 2011;42:1007-12.
30. INK4a immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping. J Gynecol Oncol 2013;24:215-21.